GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Total Stockholders Equity

PixarBio (PixarBio) Total Stockholders Equity : $0.36 Mil (As of Sep. 2016)


View and export this data going back to 2016. Start your Free Trial

What is PixarBio Total Stockholders Equity?

PixarBio's Total Stockholders Equity for the quarter that ended in Sep. 2016 was $0.36 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. PixarBio's Book Value per Share for the quarter that ended in Sep. 2016 was $0.01. The ratio of a company's debt over equity can be used to measure how leveraged this company is. PixarBio's Debt-to-Equity for the quarter that ended in Sep. 2016 was 0.00.


PixarBio Total Stockholders Equity Historical Data

The historical data trend for PixarBio's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio Total Stockholders Equity Chart

PixarBio Annual Data
Trend Dec14 Dec15
Total Stockholders Equity
0.35 0.28

PixarBio Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.27 0.28 0.24 0.19 0.36

PixarBio  (GREY:PXRB) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

PixarBio's Book Value per Share for the quarter that ended in Sep. 2016 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

PixarBio's Debt-to-Equity for the quarter that ended in Sep. 2016 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PixarBio Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PixarBio's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


PixarBio (PixarBio) Business Description

Traded in Other Exchanges
N/A
Address
200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.

PixarBio (PixarBio) Headlines